PIK3CA and breast carcinoma: Yet, Kondo et al. demonstrated, by using a glucose biosensor, that although ER+ breast cancer MCF-7 cells display increased PI3K signalling due to a heritable activating PIK3CA gene mutation, not all cells showed enhanced rates of glucose uptake and glycolysis [60].